Rob Scott is a seasoned pharmaceutical executive with nearly four decades of experience, currently serving as Head of R&D and CMO at ABIONYX Pharma. He has overseen the development of blockbuster drugs like Lipitor, Repatha, and Skyrizi. A University of Cape Town graduate, he sits on multiple biotech and venture capital boards.
His social media activity shows a strong interest in metabolic health, particularly the science behind LDL cholesterol management and the impact of diet on cardiovascular disease. He advocates for balanced, evidence-based health information over media fear-mongering and is described by colleagues as a visionary leader.
Unique fact: Born in Zimbabwe, he invented and developed Caduet, the first commercially available combination pill (Polypill) for cardiovascular disease.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.